Phibro Animal Health Corporation

PAHC · NasdaqGM

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.9%

Institutions103.8%

Public / Other

	You	Peer avg
P/E	15.7	82.7
Revenue Growth	+4.8%	+7500.0%
ROE	29.7%	16.7%

Income Statement

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30
Total money the company brought in from its core business during the period, before any costs are subtracted.	$1.30B	$1.02B	$977.89M	$942.26M	$833.35M	$800.35M	$828.00M	$819.98M	$764.28M	$751.53M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$896.27M	$704.59M	$679.65M	$656.86M	$561.97M	$543.47M	$563.37M	$553.10M	$516.04M	$512.49M
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	$399.94M	$313.09M	$298.24M	$285.40M	$271.38M	$256.88M	$264.62M	$266.88M	$248.24M	$239.03M
Gross profit as a percentage of revenue.	30.9%	30.8%	30.5%	30.3%	32.6%	32.1%	32.0%	32.5%	32.5%	31.8%
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$110.47M	$53.31M	$71.85M	$78.99M	$74.87M	$69.19M	$83.23M	$98.93M	$97.93M	$85.74M
Operating income as a percentage of revenue.	8.5%	5.2%	7.3%	8.4%	9.0%	8.6%	10.1%	12.1%	12.8%	11.4%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$48.26M	$2.42M	$32.61M	$49.17M	$54.38M	$33.55M	$54.71M	$64.88M	$64.61M	$82.73M
Net income divided by the number of shares outstanding — profit attributable to each share.	$1.19	$0.06	$0.81	$1.21	$1.34	$0.83	$1.00	$1.00	$1.00	$2.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$1.19	$0.06	$0.81	$1.21	$1.34	$0.83	$1.00	$1.00	$1.00	$2.00

Balance Sheet

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30
Cash and highly liquid short-term investments the company can access almost immediately.	$68.04M	$70.61M	$41.28M	$74.25M	$50.21M	$36.34M	$57.57M	$29.17M	$56.08M	$33.60M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$1.36B	$982.18M	$971.40M	$931.70M	$841.33M	$784.10M	$726.67M	$671.68M	$623.40M	$610.37M
All of the company's interest-bearing borrowings, short and long term combined.	–	–	–	–	–	–	–	–	$6.25M	$2.80M
Everything the company owes — debt, unpaid bills, and other obligations.	$1.08B	$725.54M	$688.89M	$669.26M	$602.80M	$595.90M	$510.66M	$486.73M	$472.24M	$519.89M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$285.68M	$256.64M	$282.51M	$262.44M	$238.53M	$188.20M	$216.01M	$184.95M	$151.16M	$90.48M

Cash Flow Statement

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$80.12M	$87.59M	$13.31M	$31.65M	$48.31M	$59.35M	$47.17M	$70.01M	$98.39M	$37.22M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$38.29M	$41.24M	$51.79M	$37.04M	$29.32M	$34.05M	$29.89M	$18.55M	$20.88M	$36.35M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$41.83M	$46.36M	-$38.48M	-$5.39M	$18.99M	$25.30M	$17.28M	$51.46M	$77.50M	$866000

Phibro Animal Health Corporation

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Peer Comparison

Income Statement

Balance Sheet

Cash Flow Statement